Search research articles
Contact Us
Filters
Showing results (171-180 of 259) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1987
Intellectual and academic achievement status after CNS relapse: a retrospective analysis of 40 children treated for acute lymphoblastic leukemia
R K Mulhern, J Ochs, D Fairclough, et al.
Journal of Clinical Immunology
|
July 18, 2017
Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
Richard L Wasserman, Isaac R Melamed, Mark R Stein, et al.
Blood
|
August 1, 1987
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species
M Bar-Ner, A Eldor, L Wasserman, et al.
Journal of Clinical Immunology
|
March 20, 2017
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex<sup>®</sup> 10% Versus Gammaplex<sup>®</sup> 5% in Subjects with Primary Immunodeficiency
Richard L Wasserman, Isaac R Melamed, Mark R Stein, et al.
Radiology Case Reports
|
April 26, 2021
MR diagnosed chronic exertional compartment syndrome successfully treated by endoscopically-assisted fasciotomy
Paul L Wasserman, Matthew Montanarella, David Szames, et al.
Immunotherapy
|
December 21, 2021
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases
Richard L Wasserman, Sudhir Gupta, Mark Stein, et al.
The Journal of Clinical Investigation
|
May 1, 1988
Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family
M M Newkirk, H Gram, G F Heinrich, et al.
International Journal of Clinical Practice
|
September 20, 2006
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction
K Sheth, R L Wasserman, W R Lincourt, et al.
Drug Safety
|
July 9, 2024
A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator
Rachel L Wasserman, Diane L Seger, Mary G Amato, et al.
Clinical Immunology (Orlando, Fla.)
|
January 14, 2014
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease
Stephen Jolles, Michael Borte, Robert P Nelson, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 259) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1987
Intellectual and academic achievement status after CNS relapse: a retrospective analysis of 40 children treated for acute lymphoblastic leukemia
R K Mulhern, J Ochs, D Fairclough, et al.
Journal of Clinical Immunology
|
July 18, 2017
Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
Richard L Wasserman, Isaac R Melamed, Mark R Stein, et al.
Blood
|
August 1, 1987
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species
M Bar-Ner, A Eldor, L Wasserman, et al.
Journal of Clinical Immunology
|
March 20, 2017
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex<sup>®</sup> 10% Versus Gammaplex<sup>®</sup> 5% in Subjects with Primary Immunodeficiency
Richard L Wasserman, Isaac R Melamed, Mark R Stein, et al.
Radiology Case Reports
|
April 26, 2021
MR diagnosed chronic exertional compartment syndrome successfully treated by endoscopically-assisted fasciotomy
Paul L Wasserman, Matthew Montanarella, David Szames, et al.
Immunotherapy
|
December 21, 2021
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases
Richard L Wasserman, Sudhir Gupta, Mark Stein, et al.
The Journal of Clinical Investigation
|
May 1, 1988
Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family
M M Newkirk, H Gram, G F Heinrich, et al.
International Journal of Clinical Practice
|
September 20, 2006
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction
K Sheth, R L Wasserman, W R Lincourt, et al.
Drug Safety
|
July 9, 2024
A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator
Rachel L Wasserman, Diane L Seger, Mary G Amato, et al.
Clinical Immunology (Orlando, Fla.)
|
January 14, 2014
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease
Stephen Jolles, Michael Borte, Robert P Nelson, et al.
Page
of 26